Technology News and Research

RSS

Nature publishes Sangamo's gene correction strategy for A1AT deficiency

Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced the publication of a preclinical study demonstrating highly specific, functional correction of the alpha 1-antitrypsin (A1AT) gene defect in patient-derived induced pluripotent stem cells (iPSCs) using zinc finger nucleases.

14 Oct 2011

Health IT incentives may not always work as intended

About half of the first batch of federal dollars meant to encourage doctors and hospitals to switch to electronic records went to providers who were converts to the technology long before the stimulus program was announced, an iWatch News analysis suggests.

14 Oct 2011

Medicaid waivers, enrollment problems plaguing states

More than a dozen House Democrats from California met recently with Medicaid boss Donald Berwick to warn him that Gov. Jerry Brown's request for deep cuts to the state/federal program would devastate healthcare providers and their patients, The Hill has learned. Brown, a Democrat, has put the Obama administration in a tough spot with his request to cut the state's Medicaid program by $1.4 billion to help plug a $26.6 billion budget gap.

14 Oct 2011

Manhattan Scientifics' nano-electromagnetic sensing technology can detect MRD in leukemia

Manhattan Scientifics announced today that the National Cancer Institute (NCI) has funded a grant for its Senior Scientific, LLC unit, for the use of its proprietary, highly precise magnetic cancer cell measurement in leukemia research for determining the progress of cancer treatment.

14 Oct 2011

EMBO, EMBC and Singapore sign cooperation agreement

Scientists in Singapore and Europe will have new avenues for scientific interaction, following a cooperation agreement between EMBO, its intergovernmental funding body, EMBC, and the government of Singapore.

14 Oct 2011

Mathematical optimization models to improve radiation therapy for cancer

Engineering researchers at the University of Arkansas have developed mathematical optimization models that will make radiation treatment plans safer and more efficient than conventional plans.

From Elekta 14 Oct 2011

NIH awards Salk Institute $4.5M to establish new Neuroscience Core Center

The National Institutes of Health has announced that the Salk Institute will receive $4.5 million to establish a Neuroscience Core Center, a new research center intended to accelerate brain research that lays the foundation for developing new ways to treat congenital brain defects and neurological diseases.

14 Oct 2011

Dual drug sneaks across the blood-brain barrier to fight HIV

In an advance toward eliminating pockets of infection in the brain that help make HIV disease incurable, scientists report the development of new substances that first plug the biological vacuum cleaner that prevents anti-HIV drugs from reaching the brain and then revert to an active drug to treat HIV.

14 Oct 2011

Tips to strengthen family connections

Combined with increasingly hectic work, school and extracurricular schedules, the advent of wireless technology has led to less quality time between parents and children. University of Missouri human development specialists say powering down digital devices is a vital step in maintaining family relationships and health.

14 Oct 2011

InnaVirVax announces Phase I/IIa clinical trial authorization for its VAC-3S HIV vaccine

InnaVirVax, a biopharmaceutical company dedicated to the development of therapeutic and diagnostic solutions in pathologies associated with immune dysregulation, declared today that it has obtained authorization from the French drug agency (AFSSAPS) to start a Phase I/IIa clinical study of its therapeutic vaccine VAC-3S for the treatment of HIV infections. This authorization intervenes only two years and half after the launching of InnaVirVax’s activities.

14 Oct 2011

Echo Therapeutics to begin Symphony tCGM System clinical study in Type 1 and Type 2 diabetes

Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 diabetes.

13 Oct 2011

Bruker acquires Center for Tribology

Bruker Corporation today announced the closing of its acquisition of Center for Tribology, Inc. (CETR) for $13 million in cash as an initial purchase price, with potential additional earn-out payments of up to $4 million in cash, depending on growth and profitability of the CETR-business within Bruker in 2012 and 2013.

From Bruker Nano Surfaces and Metrology 13 Oct 2011

U of U researchers receive NIH grant to uncover viral cause of MS

A team of investigators from the University of Utah has received a two-year, $275,000 grant from the National Institutes of Health (NIH) to fund novel research that may help to uncover a viral cause for the most acute and severe form of multiple sclerosis.

13 Oct 2011

Latest breakthroughs in lasers and optics to be discussed at 95th OSA meeting

Scientists and engineers from around the world will gather in the heart of Silicon Valley next week to discuss some of the latest breakthroughs in lasers and optics and their applications to cutting-edge science, the development of new materials, and medicine.

13 Oct 2011

'Building Sustainable Surgical Systems' conference to be held in San Diego

Today, around the world, more than two billion world citizens do not have access to emergency and essential surgical care. The results are devastating, leading to more than 500,000 maternal deaths and more than 5 million fatalities associated with everyday injuries such as road traffic accidents and burns. This lack of surgical care is arguably a top killer around the world but mostly ignored by organizations that can affect positive change.

13 Oct 2011

Roche launches LightCycler Nano real-time PCR system in the U.S.

Roche announced today the U.S. launch of the latest addition to the company's real-time PCR portfolio of LightCycler instruments for use in research, the LightCycler Nano real-time PCR system.

From Roche Sequencing and Life Science 13 Oct 2011

FDA grant to foster development of novel pediatric medical devices

The U.S. Food and Drug Administration (FDA) has awarded the Georgia Institute of Technology, Children's Healthcare of Atlanta, Emory University and Saint Joseph's Translational Research Institute (SJTRI) a two-year, $1.8 million grant to foster the development of medical devices focused on the special needs of children.

13 Oct 2011

Genetic mystery of bacterium causing ‘Black Death’ revealed

Between 1347 and 1351 - a period of just five years, Europe's Black Death wiped out about 30 million people - 30 to 50% of the population on the continent. Now geneticists have reconstructed the genome of the bacterium that caused the plague. It is found to be an ancient strain of a bacterium called Yersinia pestis very similar to the strain the exists today.

13 Oct 2011

Skin cell to liver cell shows promise for genetic liver disease

In a new scientific breakthrough, researchers have taken skin cells from a patient with liver disease and turned them into replacement liver cells. Although the procedure is years before it can be used in humans, but if approved, it could launch a new era of personalized therapies for serious genetic disorders.

13 Oct 2011

USPTO issues patent to Oragenics' In Vivo Induced Antigen Technology

Florida-based nutraceutical company, Oragenics, Inc., announced today the issuance of patent number 8,034,571 from the United States Patent and Trademark office for In Vivo Induced Antigen Technology.

13 Oct 2011